學門類別
哈佛
- General Management
- Marketing
- Entrepreneurship
- International Business
- Accounting
- Finance
- Operations Management
- Strategy
- Human Resource Management
- Social Enterprise
- Business Ethics
- Organizational Behavior
- Information Technology
- Negotiation
- Business & Government Relations
- Service Management
- Sales
- Economics
- Teaching & the Case Method
最新個案
- A practical guide to SEC ï¬nancial reporting and disclosures for successful regulatory crowdfunding
- Quality shareholders versus transient investors: The alarming case of product recalls
- The Health Equity Accelerator at Boston Medical Center
- Monosha Biotech: Growth Challenges of a Social Enterprise Brand
- Assessing the Value of Unifying and De-duplicating Customer Data, Spreadsheet Supplement
- Building an AI First Snack Company: A Hands-on Generative AI Exercise, Data Supplement
- Building an AI First Snack Company: A Hands-on Generative AI Exercise
- Board Director Dilemmas: The Tradeoffs of Board Selection
- Barbie: Reviving a Cultural Icon at Mattel (Abridged)
- Happiness Capital: A Hundred-Year-Old Family Business's Quest to Create Happiness
Purdue Pharma and the Opiod Addiction Crisis
內容大綱
By the time Purdue Pharma filed for bankruptcy in 2019, OxyContin had accumulated $35 billion in sales. In a few short years before the bankruptcy filing, the Sackler family siphoned off $13 billion in profits, making them one of the world's wealthiest billionaires. The case discusses the ethically questionable tactics that the Sackler family employed to turbocharge the supply-induced demand for OxyContin, including creating a national pain movement, obtaining FDA approval, downplaying the risks of addiction, ignoring symptoms of addiction, ambitious sales representatives, targeting high prescribers, pampering physicians, addressing regulatory changes, and hiring McKinsey. Purdue Pharma coopted regulators, medical accreditation boards, hospitals, and doctors to do their bidding. As a result, over one million Americans have died from drug overdoses since 2000.